Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
InfuSystem Holdings, Inc. is a U.S.-based healthcare services company that provides infusion pump management solutions primarily to the outpatient healthcare market. The company operates within the medical technology and healthcare services industries, focusing on the delivery, maintenance, tracking, and billing support of ambulatory infusion pumps used for therapies such as oncology, pain management, and specialty infusions. Its core value proposition is enabling healthcare providers to efficiently administer infusion-based treatments outside of acute care settings while reducing operational complexity.
The company’s primary revenue drivers are recurring service fees associated with its pump fleet and related services provided to oncology clinics, hospitals, and home infusion providers. InfuSystem is positioned as a specialized outsourced solutions provider, differentiating itself through scale, regulatory compliance expertise, and integrated logistics and billing support. Founded in 1981, the company initially operated as an infusion pump rental business and evolved over time into a publicly traded healthcare services platform, completing its transition to its current name, InfuSystem Holdings, Inc., in 2007.
Business Operations
InfuSystem generates revenue primarily through its Infusion Pump Services segment, which encompasses the rental, servicing, and logistics management of ambulatory infusion pumps. The company owns and manages a large fleet of infusion devices and provides end-to-end services including device delivery, retrieval, cleaning, testing, maintenance, and compliance documentation. These services are typically provided under long-term contractual arrangements, supporting recurring revenue and high asset utilization.
Operations are concentrated in the United States, with a national service infrastructure that supports both community-based oncology practices and larger health systems. InfuSystem also operates the Durable Medical Equipment (DME) and related service offerings that support infusion therapy workflows. The company controls proprietary logistics processes, tracking systems, and service protocols designed to meet regulatory and payer requirements. Its operations are supported by wholly owned subsidiaries, including InfuSystem, Inc., which conducts the core operating activities.
Strategic Position & Investments
InfuSystem’s strategic direction centers on expanding its role in the shift of infusion therapies from inpatient to outpatient and home-based settings. Growth initiatives include increasing penetration within oncology and specialty infusion markets, expanding pump utilization rates, and enhancing service offerings that integrate logistics, compliance, and data visibility for providers. The company has emphasized operational efficiency, fleet optimization, and disciplined capital allocation as key strategic priorities.
The company has pursued targeted acquisitions to broaden its service capabilities and customer reach, including the acquisition of TriSalus Life Sciences’ clinical service assets and other smaller strategic investments designed to complement its infusion services platform. InfuSystem has also invested in emerging care delivery models that support home infusion and alternative sites of care, aligning its asset base with long-term healthcare cost-containment trends and value-based care initiatives.
Geographic Footprint
InfuSystem is headquartered in Madison Heights, Michigan, and its operations are primarily concentrated in North America, with a strong footprint across the United States. The company services healthcare providers in a wide range of metropolitan and regional markets, supported by centralized logistics and service centers that enable nationwide coverage.
While international exposure is limited, InfuSystem has historically reported some operations and customers in Canada, though the U.S. market represents the substantial majority of revenue and assets. The company’s geographic strategy emphasizes depth of service and density within existing markets rather than broad international expansion.
Leadership & Governance
InfuSystem is led by an experienced management team with backgrounds in healthcare services, medical devices, and operational execution. Leadership emphasizes disciplined growth, regulatory compliance, and long-term value creation through recurring revenue and asset efficiency. The company operates under a governance framework aligned with U.S. public company standards and is overseen by an independent board of directors.
Key executives include:
- Richard Dilorio – Chief Executive Officer and President
- Andrew D. Paquette – Chief Financial Officer
- Randi J. Moskovitz – Chief Operating Officer
- Michael J. Cannata – Chief Commercial Officer
- Jonathan P. Foster – General Counsel and Secretary
The leadership team’s strategic vision focuses on strengthening InfuSystem’s position as a critical infrastructure partner for outpatient infusion therapy while maintaining financial discipline and regulatory rigor.